David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SLB Ltd
SLB
$79.9B
| $119M | 0.18% |
1,705,306
-2,750,036
| -62% | -$182M |
|
127
Medtronic
MDT
$119B
| $119M | 0.18% |
1,526,306
+908,030
| +147% | +$75.4M |
|
128
Vanguard Real Estate ETF
VNQ
$39.1B
| $119M | 0.18% |
1,426,625
| – | – |
|
129
Masco
MAS
$14.5B
| $117M | 0.18% |
3,007,706
+284,753
| +10% | +$10.7M |
|
130
CALL
Microsoft
MSFT
$3.59T
| $116M | 0.18% |
1,559,000
-367,900
| -19% | -$26.9M |
|
131
Alnylam Pharmaceuticals
ALNY
$31.6B
| $115M | 0.18% |
982,454
+248,804
| +34% | +$21.2M |
|
132
PUT
JPMorgan Chase
JPM
$935B
| $115M | 0.18% |
1,204,200
-515,100
| -30% | -$47.5M |
|
133
CALL
ExxonMobil
XOM
$679B
| $114M | 0.18% |
1,392,000
+443,400
| +47% | +$35.2M |
|
|
134
JPMorgan Chase
JPM
$935B
| $113M | 0.17% |
1,183,380
-977,234
| -45% | -$90.1M |
|
135
Baker Hughes
BKR
$61.9B
| $113M | 0.17% |
+3,076,914
| New | +$109M |
|
136
Pfizer
PFE
$160B
| $113M | 0.17% |
3,323,151
-1,362,790
| -29% | -$43.8M |
|
137
Motorola Solutions
MSI
$79.5B
| $111M | 0.17% |
1,313,633
+13,545
| +1% | +$1.19M |
|
|
138
PUT
Qualcomm
QCOM
$169B
| $111M | 0.17% |
2,150,300
+1,208,100
| +128% | +$63.9M |
|
139
PUT
Chipotle Mexican Grill
CMG
$46.7B
| $111M | 0.17% |
18,035,000
+6,490,000
| +56% | +$43.7M |
|
|
CJ
140
DELISTED
C&J Energy Services, Inc.
CJ
| $111M | 0.17% |
3,699,374
-100,839
| -3% | -$2.99M |
|
141
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $111M | 0.17% |
1,861,034
+20,000
| +1% | +$1.17M |
|
142
Yelp
YELP
$1.27B
| $109M | 0.17% |
2,521,204
+1,127,799
| +81% | +$43.5M |
|
143
Zoetis
ZTS
$32.1B
| $108M | 0.17% |
1,690,598
+639,258
| +61% | +$40M |
|
|
144
PUT
Wells Fargo
WFC
$254B
| $107M | 0.16% |
1,945,100
+790,900
| +69% | +$42M |
|
145
PUT
Micron Technology
MU
$1.09T
| $106M | 0.16% |
2,703,500
+795,900
| +42% | +$25.2M |
|
146
Altria Group
MO
$110B
| $106M | 0.16% |
1,672,789
+611,579
| +58% | +$40.8M |
|
147
Air Products & Chemicals
APD
$67.9B
| $106M | 0.16% |
698,083
+109,499
| +19% | +$16M |
|
148
PUT
Baidu
BIDU
$31.6B
| $103M | 0.16% |
416,900
+376,900
| +942% | +$82.2M |
|
149
PUT
Boeing
BA
$169B
| $103M | 0.16% |
404,500
+96,800
| +31% | +$22.6M |
|
150
Coca-Cola
KO
$392B
| $102M | 0.16% |
2,276,067
+2,121,568
| +1,373% | +$96.5M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.